Top

Current Treatment Options in Oncology

Published in:

01-06-2008 | Geriatric Oncology

Anticancer Drug Therapy in the Older Cancer Patient: Pharmacology and Polypharmacy

Authors: Stuart M. Lichtman, MD, Manpreet K. Boparai, PharmD

Published in: Current Treatment Options in Oncology | Issue 2-3/2008

Title: Anticancer Drug Therapy in the Older Cancer Patient: Pharmacology and Polypharmacy
Authors: Stuart M. Lichtman, MD
Manpreet K. Boparai, PharmD
Publication date: 01-06-2008
Publisher: Springer US
Published in: Current Treatment Options in Oncology / Issue 2-3/2008
Print ISSN: 1527-2729
Electronic ISSN: 1534-6277
DOI: https://doi.org/10.1007/s11864-008-0060-6

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 2-3/2008

Acupuncture as an Evidence-Based Option for Symptom Control in Cancer Patients

Mind–Body Interventions in Oncology

Mesothelioma Epidemiology, Carcinogenesis, and Pathogenesis

Pain Management for Hepatobiliary Cancer

Symptom Management in Geriatric Oncology: Practical Treatment Considerations and Current Challenges

Herbs and Other Botanicals in Cancer Patient Care

Keynote webinar | Spotlight on antibody–drug conjugates in cancer